Skip to content

Development and Validation of an Interpretable Machine Learning Model for Predicting Outcomes in Patients with Acute-on-Chronic Liver Failure and Sepsis Undergoing Artificial Liver Therapy: A Multicenter Clinical Study

Development and Validation of an Interpretable Machine Learning Model for Predicting Outcomes in Patients with Acute-on-Chronic Liver Failure and Sepsis Undergoing Artificial Liver Therapy: A Multicenter Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114333
Enrollment
Unknown
Registered
2025-12-10
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute-on-chronic liver failure with sepsis

Interventions

Observation group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Simultaneously meet the diagnostic criteria for acute-on-chronic liver failure (ACLF) and sepsis. The diagnostic criteria for ACLF refer to the "Guidelines for the Diagnosis and Treatment of Liver Failure (2024 Edition)" and the Chinese Severe Hepatitis B Study Group (COSSH-ACLF) standards: on the basis of chronic liver disease (with or without cirrhosis), acute deterioration of liver function caused by various triggers, accompanied by liver and/or extrahepatic organ failure, with total bilirubin (TBIL) >= 12 mg/dL (205 µmol/L) and PT-INR >= 1.5; the diagnostic criteria for sepsis refer to the International Sepsis 3.0 standards, that is, infection with a SOFA score > 2; 2. Have received at least one session of artificial liver support therapy; Applicable to Part One: those with relatively complete records; applicable to Part Two: individuals who voluntarily participate in this study and are willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Age < 18 years; 2.Pregnancy; 3.Malignancy; 4.Declined to participate in the clinical study; 5.Hospital stay < 24 hours.

Design outcomes

Primary

MeasureTime frame
All-cause death;

Secondary

MeasureTime frame
Baseline characteristics (including age, gender, height, weight);Initial Laboratory and Artificial Liver Treatment Examination Results (Before and After Hospitalization) - White Blood Cells, Neutrophil Count, Lymphocyte Count, Red Blood Cells, Hemoglobin, Platelet Count, ALT, AST, TBIL, ALB, BUN, SCr, UA, Sodium Ion, Potassium Ion, Chloride Ion, Blood Lactic Acid, CRP, PCT, IL-6;

Countries

CHina

Contacts

Public ContactKunping Cui

West China Hospital of Sichuan University

18215629811@163.com+86 182 1562 9811

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026